Learn More
R&D Systems™ Human IL-31 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
$402.50
Specifications
Gene ID (Entrez) | 386653 |
---|---|
Molecular Weight (g/mol) | 15.8 kDa |
Name | IL-31 |
Quantity | 10μg |
Source | E. coli-derived human IL-31 protein Ser24-Thr164 |
Catalog Number | Mfr. No. | Formulation | Price | Quantity & Availability | |||||
---|---|---|---|---|---|---|---|---|---|
Catalog Number | Mfr. No. | Formulation | Price | Quantity & Availability | |||||
2824IL010CF
|
R&D Systems™
2824IL010/CF |
Lyophilized from a 0.2μm filtered solution in PBS. |
Each for $402.50
|
|
|||||
2824IL010
|
R&D Systems™
2824IL010 |
Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. |
Each for $402.50
|
|
|||||
Description
The Recombinant Human IL-31 Protein is derived from E. coli. The Recombinant Human IL-31 Protein has been validated for the following applications: Bioactivity.Specifications
386653 | |
IL-31 | |
E. coli-derived human IL-31 protein Ser24-Thr164 | |
Unconjugated | |
95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
15.8 kDa | |
10μg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
Recombinant |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.